IBDEI1H6 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24659,1,3,0)
 ;;=3^HIV+ (Symptomatic)/AIDS
 ;;^UTILITY(U,$J,358.3,24659,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,24659,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,24660,0)
 ;;=Z23.^^121^1222^28
 ;;^UTILITY(U,$J,358.3,24660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24660,1,3,0)
 ;;=3^Encounter for Immunization
 ;;^UTILITY(U,$J,358.3,24660,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,24660,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,24661,0)
 ;;=Z20.828^^121^1222^17
 ;;^UTILITY(U,$J,358.3,24661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24661,1,3,0)
 ;;=3^Contact/Exposure to Viral Diseases
 ;;^UTILITY(U,$J,358.3,24661,1,4,0)
 ;;=4^Z20.828
 ;;^UTILITY(U,$J,358.3,24661,2)
 ;;=^5062774
 ;;^UTILITY(U,$J,358.3,24662,0)
 ;;=Z77.21^^121^1222^16
 ;;^UTILITY(U,$J,358.3,24662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24662,1,3,0)
 ;;=3^Contact/Exposure to Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,24662,1,4,0)
 ;;=4^Z77.21
 ;;^UTILITY(U,$J,358.3,24662,2)
 ;;=^5063323
 ;;^UTILITY(U,$J,358.3,24663,0)
 ;;=Z72.51^^121^1222^56
 ;;^UTILITY(U,$J,358.3,24663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24663,1,3,0)
 ;;=3^High Risk Sexual Behaviors
 ;;^UTILITY(U,$J,358.3,24663,1,4,0)
 ;;=4^Z72.51
 ;;^UTILITY(U,$J,358.3,24663,2)
 ;;=^5063258
 ;;^UTILITY(U,$J,358.3,24664,0)
 ;;=Z79.899^^121^1222^66
 ;;^UTILITY(U,$J,358.3,24664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24664,1,3,0)
 ;;=3^Long Term Use of Medications
 ;;^UTILITY(U,$J,358.3,24664,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,24664,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,24665,0)
 ;;=A06.9^^121^1222^1
 ;;^UTILITY(U,$J,358.3,24665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24665,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,24665,1,4,0)
 ;;=4^A06.9
 ;;^UTILITY(U,$J,358.3,24665,2)
 ;;=^5000048
 ;;^UTILITY(U,$J,358.3,24666,0)
 ;;=K60.2^^121^1222^2
 ;;^UTILITY(U,$J,358.3,24666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24666,1,3,0)
 ;;=3^Anal Fissure
 ;;^UTILITY(U,$J,358.3,24666,1,4,0)
 ;;=4^K60.2
 ;;^UTILITY(U,$J,358.3,24666,2)
 ;;=^5008747
 ;;^UTILITY(U,$J,358.3,24667,0)
 ;;=K60.3^^121^1222^3
 ;;^UTILITY(U,$J,358.3,24667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24667,1,3,0)
 ;;=3^Anal Fistula
 ;;^UTILITY(U,$J,358.3,24667,1,4,0)
 ;;=4^K60.3
 ;;^UTILITY(U,$J,358.3,24667,2)
 ;;=^6684
 ;;^UTILITY(U,$J,358.3,24668,0)
 ;;=K62.82^^121^1222^4
 ;;^UTILITY(U,$J,358.3,24668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24668,1,3,0)
 ;;=3^Anal Intraepithelial Neoplasia/AIN
 ;;^UTILITY(U,$J,358.3,24668,1,4,0)
 ;;=4^K62.82
 ;;^UTILITY(U,$J,358.3,24668,2)
 ;;=^5008758
 ;;^UTILITY(U,$J,358.3,24669,0)
 ;;=D64.9^^121^1222^5
 ;;^UTILITY(U,$J,358.3,24669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24669,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,24669,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,24669,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,24670,0)
 ;;=R64.^^121^1222^6
 ;;^UTILITY(U,$J,358.3,24670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24670,1,3,0)
 ;;=3^Cachexia
 ;;^UTILITY(U,$J,358.3,24670,1,4,0)
 ;;=4^R64.
 ;;^UTILITY(U,$J,358.3,24670,2)
 ;;=^17920
 ;;^UTILITY(U,$J,358.3,24671,0)
 ;;=B37.81^^121^1222^7
 ;;^UTILITY(U,$J,358.3,24671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24671,1,3,0)
 ;;=3^Candidiasis,Esophageal
 ;;^UTILITY(U,$J,358.3,24671,1,4,0)
 ;;=4^B37.81
 ;;^UTILITY(U,$J,358.3,24671,2)
 ;;=^5000620
 ;;^UTILITY(U,$J,358.3,24672,0)
 ;;=B37.0^^121^1222^8
 ;;^UTILITY(U,$J,358.3,24672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24672,1,3,0)
 ;;=3^Candidiasis,Oropharyngeal
 ;;^UTILITY(U,$J,358.3,24672,1,4,0)
 ;;=4^B37.0
